We are a dynamic team at the Department of Oncology–Pathology at Karolinska Institutet, bringing together clinicians, molecular biologists, bioinformaticians, epidemiologists, biostatisticians, and AI engineers. We conduct clinical research in breast cancer and combine it with molecular profiling of tumor tissue and blood to understand treatment resistance and discover clinically useful, treatment-predictive biomarkers.
Our mission is to (a) understand breast cancer, by uncovering the biological, molecular, and clinical mechanisms that drive resistance and disease progression, and (b) advance precision oncology, by developing and validating biomarkers that can guide personalized treatment and improve patient outcomes.
To achieve this, we integrate clinical studies, molecular biology, bioinformatics, and artificial intelligence in a highly collaborative environment. We develop and apply cutting-edge methods—from spatial in situ technologies and single-cell omics to digital pathology and multimodal AI—to uncover patterns that shape tumor behavior and therapy response.
We are based at Bioclinicum, Karolinska Institutet (Solna), in Stockholm. Embedded in a leading clinical and translational research setting, we collaborate closely with groups in oncology, molecular biology, bioinformatics, and AI-driven precision medicine. We participate in EU-funded projects and maintain collaborations with leading institutions across Europe, the US, and worldwide. We regularly attend international meetings (ESMO, ASCO, SABCS) and welcome opportunities to connect and collaborate with colleagues who share our passion for translational cancer science.
23 January 2026
Kang finishes his PhD! Huge congratulations to Dr. Wang, who has done an amazing job these past years and defended his doctoral thesis on January 23, 2026. His oponent was renowned breast cancer researcher Professor Charles M. Perou from the University of North Carolina at Chapel Hill (USA). His dissertation was titled ‘Delineating the molecular landscape of breast cancer and response to neoadjuvant systemic treatment’, you can read more here. 
24 October 2025
Congrats to Caroline Boman for successfully defending her PhD thesis today 🎓! Her dissertation is titled ‘Breast cancer biomarkers, dynamics during treatment and metastatic progression’. You can read it here. 
16 September 2025
Getting the right breast cancer therapy to the right patient is an interview done by KI to Theodoros Foukakis approaching the ceremony for newly appointed professors on October 9, 2025. Theo was appointed Professor of Oncology on April 2, 2025. The installation ceremony took place in Aula Medica, where 22 new professors at KI were inaugurated. Congrats! 🎉 Read more (and watch a video) here. 
